Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis.

Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, Boffetta P.

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1473-9.

2.

Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study.

Smits KM, Gaspari L, Weijenberg MP, Dolzan V, Golka K, Roemer HC, Nedelcheva Kristensen V, Lechner MC, Mehling GI, Seidegard J, Strange RC, Taioli E.

Biomarkers. 2003 May-Aug;8(3-4):299-310.

PMID:
12944179
3.

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.

Sarmanová J, Benesová K, Gut I, Nedelcheva-Kristensen V, Tynková L, Soucek P.

Hum Mol Genet. 2001 Jun 1;10(12):1265-73.

PMID:
11406608
4.

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lønning PE, Erikstein B, Kåresen R, Gabrielsen OS, Børresen-Dale AL.

Cancer Res. 1999 Jun 15;59(12):2825-8.

5.

Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.

Nedelcheva Kristensen V, Andersen TI, Erikstein B, Geitvik G, Skovlund E, Nesland JM, Børresen-Dale AL.

Pharmacogenetics. 1998 Oct;8(5):441-7. Erratum in: Pharmacogenetics 1999 Feb;9(1):following 127.

PMID:
9825836

Supplemental Content

Loading ...
Support Center